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Abstract
Objective To investigate the long-term outcome of ini-
tially dilated/aneurysmatic coronary arteries in Kawasaki
disease (KD) and to define risk factors for significant
myocardial ischemia during follow-up, we retrospectively
followed all pediatric patients with proven acute coronary
changes due to KD in our institution.
Methods and results Since 1981, 38 children have been
identified with coronary changes due to KD. The median
age was 1.2 years (0.1–12.8). In 37 patients therapy with
intravenous immunoglobulin was initiated within 9 days
(1–30) after the beginning of KD. All received aspirin and
three additionally received steroids. Median follow-up was
8.5 years (0.5–24.8). We defined two groups: A aneurysm/
ectasia of the coronary artery B5.0 mm (n = 23) and B
aneurysm size [5.0 mm (n = 15). During follow-up, all
coronary aneurysms of group A regressed to normal size,
whereas in 14 patients of group B (93%) the aneurysms
persisted or even increased in size. Four patients of group B
developed severe coronary stenosis at the proximal and/or
distal end of the aneurysm and needed an intervention
(endovascular balloon dilation and stent implantation
(n = 2) or bypass surgery (n = 2)) after a median time
interval of 9.8 years (1.0–15.6) after KD. They all had
ECG changes preceding the intervention about 1 year in
advance. Maximum aneurysm size[5 mm was a statistical
significant predictive risk factor for myocardial ischemia.
Conclusions After KD, patients with a coronary aneu-
rysm size [5.0 mm need close follow-up assessments
because of an elevated risk for the development of coro-
nary stenotic lesions. In case of new and even unspecific
ECG changes, coronary imaging modalities (angiography,
MRI) have to be considered. Therapy options vary from
percutaneous catheter interventions to bypass surgery and
have to be selected individually for each patient.
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Introduction
Kawasaki disease (KD) is the most common cause of
multisystem vasculitis in childhood. Since its first
description by Tomisaku Kawasaki [13], it has now
replaced rheumatic fever as the number one acquired heart
disease in children of the developed world, due to its
predilection for the coronary arteries [23, 25, 31].
The disease is still associated with the mortality, mostly
due to the coronary artery changes. Giant aneurysms can
occur, and are unlikely to resolve, and may develop ste-
nosis during follow-up with the risk of coronary throm-
bosis, myocardial infarction and death [1, 2, 5, 6].
Therefore, the early detection of indicating factors can be
of great benefit [8].
The objective of this study was to present the long-term
follow-up of pediatric patients with coronary changes due
to KD, and to define predictive risk factors for significant
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myocardial ischemia after KD requiring an intervention
during follow-up, and to describe different therapy options
for these specific obstructive lesions.
Methods
Patients and study design
In this retrospective study, we followed all patients with
acute coronary artery changes due to KD between
December 1981 and 2005. The following variables were
analyzed: age at onset of the disease, gender, localization
and aneurysm size of affected coronary artery, and onset of
acute therapy for KD. During follow-up, we investigated
the course of aneurysm size, abnormalities of electrocar-
diography (ECG), therapy of coronary artery stenosis, and
outcome of interventions for stenotic lesions.
Routine follow-up assessment includes physical exami-
nation, ECG, echocardiography and ergometric exercise
testing. We do not routinely perform other tests to evaluate
possible coronary stenosis and myocardial ischemia in
every patient after KD. But in patients with known coro-
nary involvement greater than or equal to risk level III
(isolated small to medium coronary aneurysm in C1 cor-
onary artery) we perform stress tests with myocardial
perfusion [perfusion magnetic resonance imaging (MRI)]
every 2 years (every year in patients with risk level IV and
V) in pts [10 years, according to the recommendations of
the American Academy of Pediatrics [21]. In addition,
coronary angiographies or magnetic resonance imaging
(MRI) perfusion scans were performed in patients with
abnormalities in ECG, pathologic changes during exercise
testing or clinical episodes of chest pain.
For further risk factor analysis, we defined two groups of
the size of coronary arteries: group A with coronary
aneurysm/ectasia B5.0 mm, group B with coronary aneu-
rysm [5.0 mm.
Approval was obtained from the local ethics committee.
Statistical analysis
Data are given as median and range. Intervention-free
course after diagnosis of KD was analyzed by the Kaplan–
Meier method, and differences were assessed by the log-
rank test. Predictive risk factors, such as age, sex, begin of
IVIG therapy, size of coronary ectasia/aneurysm, localiza-
tion of coronary aneurysm (RCA vs. LCA), and ECG
abnormalities during follow-up for the development of
coronary artery stenosis were analyzed with Cox regression.
A P value \0.05 is considered statistically significant.
Statistical analysis was performed using SPSS 12 for
MacOSXTM (Chicago, IL).
Results
Patients and clinical course
Thirty-eight patients were diagnosed with acute coronary
changes/dilatations due to KD, which reflects an incidence
of coronary changes in 21% of all patients during this time
period. The age at onset of KD in the 38 afflicted patients
ranged from 0.1 to 12.8 years (median 1.2 years). The
patients were mainly male (male:female = 24:14). Left
coronary artery (LCA) was more often affected than right
coronary artery (RCA) (Table 1). In 37 of 38 cases,
intravenous immunoglobulin (IVIG) therapy was started
after a median of 9 days (1–440 days) after the onset of
KD. In addition, three patients received steroids. One
patient did not receive IVIG or steroids due to the late
diagnosis. High-dose aspirin (ASA) was initially given to
all patients (Table 2).
During follow-up, all patients with known coronary
aneurysms were left on low-dose ASA, at least until the
aneurysm regressed. Patients with giant aneurysms
received an oral anticoagulation with marcumar [20].
Follow-up time after KD was 8.5 (0.1–24.8) years—for
patients in group A 6.4 (0.5–18.8) years and for patients in
group B 8.7 (0.9–24.8) years.
Coronary arteries
According to their maximum size of coronary artery dila-
tation, 23 patients belonged to group A (coronary aneu-
rysm/ectasia B5.0 mm), and 15 patients to group B
(coronary aneurysm [5.0 mm).
During follow-up, all coronary aneurysms of group A
regressed to normal size, whereas in 14 patients of group B
(93%) the aneurysms persisted or even increased in size
(Fig. 1).
Table 1 Characteristics of 38 patients, who have been detected with
acute coronary artery changes during Kawasaki disease
Patient data (n = 38)
Age at onset of KD (years) 1.2 (0.01–12.8)
Sex (M:F) 24:14
Therapy begin after onset of KD (days) 9 (1–440)
Affected coronary—LCA: RCA 31:7
Maximum aneurysm size 5 (2.8–23)
Group A (coronary aneurysm/ectasia B5.0 mm) n = 23
Group B (coronary aneurysm [5.0 mm) n = 15
Follow-up (years) 8.5 (0.5–24.8)
Values are expressed as median and range
LCA left coronary artery, RCA right coronary artery
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Four patients with a coronary aneurysm size [5 mm
(27% of group B) developed severe coronary artery ste-
nosis at the proximal or distal end of the aneurysm
requiring an intervention after a median interval of
9.8 years (Table 4).
Therefore, the intervention-free course after diagnosis of
KD is shown in Fig. 2.
A diameter of the coronary ectasia/aneurysm [5.0 mm
during or after acute KD is a predictive value for the
development of stenotic coronary lesions (P = 0.04).
Electrocardiography abnormalities during follow-up
were registered in five patients. They were partly combined
with clinical symptoms of myocardial ischemia, which
occurred several months later. Diagnostic work up con-
firmed severe obstructive coronary lesion by perfusion
MRI in two, selective coronary angiography in two and
could be excluded in one patient. ECG abnormalities are a
predictive risk factor (P = 0.0001).
Differences in age, gender, localization of coronary
aneurysm and the onset of IVIG therapy did not have a
significant influence (Table 3).
Interventions (Table 4)
Two of the four patients with significant coronary stenosis
during follow-up primarily received an endovascular inter-
vention for their coronary stenosis. They developed their
stenosis late after initial KD, with an interval of 15.5 and
14.7 years, respectively. In both cases, unspecific ECG
changes and in one case additional symptoms as exercise-
induced dyspnea and syncope, which occurred 10 months
after these initial ECG changes, led to further investigations.
MRI perfusion scan demonstrated a perfusion defect at first
pass in the territory of the left anterior descending artery
(LAD) in both patients (Fig. 3). This single vessel disease
was intended to be treated percutaneously in both. Coronary
arterial angiography confirmed the singular severe and
partly calcified stenosis at the proximal end of the former
aneurysm site (Fig. 4). A percutaneous transluminal coro-
nary angioplasty (PTCA) alone was not successful in these
calcified stenotic vessels. Therefore, both patients received
an additional coronary stent implantation, one coronary bare
metal stent (BMS) and one drug-eluting stent (DES), with a
satisfactory result. Despite an adequate antiplatelet therapy
with ASA (100 mg per day) and clopidogrel (75 mg per
day), one patient suffered from a complete thrombotic
occlusion of the implanted stent 1 month after intervention.
Taking into account the age of the young patient, and the
morphology, and vulnerability of the affected coronary, he
then received a coronary bypass operation utilizing the
pedicled internal thoracic artery. The peripheral coronary
perfusion was restored, no cardiac sequelae occurred.
Two other patients with large (giant) and bilateral coro-
nary aneurysms without any significant regression primarily
received a surgical revascularization for their coronary
stenosis. Both patients complained of subjective symptoms
of myocardial ischemia during exercise, 1 and 4.7 years
after KD, respectively. Unspecific ECG changes had
already been registered about 1 year in advance in both
patients. A selective coronary arteriography revealed a
complete occlusion of the RCA and LAD with insufficient
collateral circulation in one patient, and in the other one a
severe stenosis ([90%) of the RCA and LAD. The stenotic
lesions were localized at the proximal and/or distal end of
the aneurysms. A combined surgical approach with the
resection of the large aneurysms (aneurysmectomy) and
bypass surgery was chosen in both cases. One patient
received a bilateral anastomosis of his internal thoracic
artery with LAD and RCA, and two supplementary venous
Table 2 Characteristics of the study groups
Coronary aneurysm/ectasia size Group A
(B5.0 mm)
Group B
([5.0 mm)
Number of patients 23 15
Age at onset of disease (years) 1.3 (0.02–12.8) 0.8 (0.2–10.1)
Sex (M:F) 16:7 8:7
Maximum aneurysm size (mm) 3.5 (2.8–5.0) 8.0 (5.8–23.0)
Interventions 0 4
Values are expressed as median and range
Fig. 1 Fate of initial coronary
aneurysms during follow-up
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grafts of autologous saphenous veins (CABG coronary
artery bypass grafting). Although a standard antiplatelet
therapy with ASA was initiated, a control angiography
6 months after surgery showed a complete occlusion of both
venous grafts and patent arterial grafts. Without any signs of
considerable myocardial ischemia, further percutaneous or
surgical interventions were not necessary. In the other
patient, a single arterial bypass of his left internal thoracic
artery to LAD was sufficient to restore complete coronary
perfusion, beside the bilateral aneurysmectomy. Control
angiography after 6 months showed a patent arterial bypass.
8 years after the operation, the patient is still doing well
without any clinical signs of myocardial ischemia.
Discussion
Morbidity and mortality of KD still exist mostly because of
its predilection for the coronary arteries. Acute coronary
changes/dilatations can occur in 10–20% of KD patients [8,
21, 23]. They comprise coronary vasculitis with the
destruction of the internal elastic lamina, thrombocytosis
and hypercoagubility. Accordingly, in our patient group,
the rate of acute coronary affection/dilatation was 21%.
Many previous studies have looked at putative predic-
tors of acute coronary artery lesion development in KD.
They investigated demographic, clinical, and laboratory
variables [3, 9, 15]. Male gender, young age at diagnosis,
long duration of fever, and low-serum albumin level have
been identified as high-risk factors. Harada [9] suggested a
set of high-risk criteria to facilitate a rationale decision-
making for IVIG therapy.
After the acute phase, histopathological findings show
an arterial remodeling with more or less progressive
thickening of the intima because of smooth muscle cell
proliferation, followed by a neoangiogenese of microves-
sels and a fibrotic proliferation [21]. Approximately 50% of
coronary aneurysms occurring in the acute stage of the
disease were shown to regress within several years [10, 12].
Smaller, as well as fusiform, rather than saccular, and
distally located aneurysms have a greater likelihood of
regression [19].
However, the risk of thrombotic occlusion and sudden
cardiac death remains for some patients [30].
The primary question addressed in this study is possible
risk factors for the development of significant coronary
artery lesions during long-term follow-up.
In our patient group of 38 patients with detectable
coronary aneurysms/ectasias due to KD, we were able to
show that during follow-up 93% of all aneurysms sized
[5 mm persisted or even increased in size, whereas
smaller aneurysms all regressed completely. 15.5 years
after KD, already 25% of the patients with an initial
aneurysm size [5 mm had developed severe coronary
stenosis at the proximal and/or distal end of the aneurysm
and needed an intervention, either surgically or by catheter
intervention. Maximum aneurysm size [5 mm was a sta-
tistical significant predictive risk factor for late myocardial
ischemia. Age, gender, localization of coronary aneurysm,
and the beginning of IVIG therapy did not have a signifi-
cant influence.
Giant aneurysms with a maximum diameter C8 mm
have been reported to have the worst prognosis with regard
to the development of significant coronary stenosis [26,
27]. Progressive myointimal proliferation in combination
with sluggish blood flow within the extremely dilated
vessels and continuous thrombus apposition can cause the
fatal vessel narrowing, typically at the proximal or distal
end of the aneurysm [10, 15]. Beside these structural
abnormalities, coronary ischemia may also result in late
functional abnormalities of the coronary endothelium with
abnormal vasoreactivity [7]. After several years, at least
Table 3 Influence of different continuous variables on event-free
survival after KD analyzed with Cox regression
Risk factor P value
Age 0.299
Sex 0.114
LCA versus RCA 0.582
Therapy (IVIG) delay 0.950
ECG changes 0.0001
Aneurysm size 0.008
Group A versus group B 0.004
A P value \0.05 was considered statistically significant
1.0
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Aneurysm size ≤ 5.0mm (group A) 
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Fig. 2 Kaplan–Meier survival analysis demonstrating the interven-
tion-free course after diagnosis of KD in patients with coronary
aneurysm/ectasia size B5.0 mm (group A) and with aneurysm size
[5.0 mm (group B). The course of both groups was significantly
different (P \ 0.04)
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6–8 years, the coronary vascular stiffness may additionally
be deteriorated by progressive calcifications [1, 11].
The time-span between the onset of the disease and
development of coronary stenosis varies from several
months to 45 years [26, 28, 29]. Also in our patients with
significant coronary stenosis requiring an intervention this
time interval varied from 1 to 15.5 (median 9.8) years.
All of them had ECG changes preceding the intervention
about 1 year in advance. These unspecific ECG changes
had a highly significant predictive value for coronary
obstructions during follow-up after KD (P = 0.0001).
Table 4 Specific data of four patients with coronary arterial stenosis requiring a coronary intervention during follow-up (Primarily percutaneous
intervention in cases 1 and 2, primarily bypass surgery in cases 3 and 4)
1 2 3 4
Sex F M F F
Age at onset of KD (years) 0.26 0.46 0.24 9.67
Max. aneurysm size (mm) 8 7.5 23 10
Interval disease—procedure (years) 15.5 14.7 4.7 1
Age at procedure (years) 16 15.2 5 10.6
Intervention site LAD LAD LAD/RCA LAD/RCA
Symptoms Syncope, dyspnea – Angina pectoris Angina pectoris
ECG changes Yes Yes Yes Yes
MRI/Angiography ?/? ?/? -/? -/?
Procedure PTCA and BMS PTCA and DES 2 9 CAB/2 9 ACVB
Aneurysm-ectomy
1 9 CAB
Aneurysm-ectomy
Complications of the procedure No No No No
Follow-up after procedure (years) 0.6 0.6 7.9 8
Patency of coronary/grafts Restenosis after 1 month Open Occlusion of venous graft Open
Re-intervention CAB – – –
LAD left anterior descending artery, RCA right coronary artery, PTCA percutaneous transluminal coronary angioplasty, BMS bare-metal
coronary stent, DES drug-eluting coronary stent, ACVB aortocoronary venous bypass, CAB coronary arterial bypass
Fig. 3 Magnetic resonance imaging scan demonstrating first-pass
perfusion defect of the LAD territory in a patient with total occlusion
of LAD
Fig. 4 Coronary arterial angiography showing the singular severe
stenosis at the former aneurysm site in the proximal LAD. The
stenosis is located at the proximal end of the residual aneurysm and is
partly calcified
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Different imaging modalities exist to confirm the sus-
pected coronary lesion after KD. Echocardiography allows
to measure proximal coronary artery dimensions. In addi-
tion, it also may reveal the lack of normal tapering and
perivascular echogenicity. X-ray coronary angiography is
the classic technique to evaluate coronary arteries more
exactly, but it is an invasive and radiation method. MRI has
proven to be a valuable tool to evaluate the coronary artery
origin and proximal course in children and adults with KD
[17, 18]. It also has the advantage of simultaneous perfu-
sion, function, and viability evaluation [17]. However,
there are limitations to reliably detect coronary artery
lesions and perfusion defects in small children with higher
heart rates. In small children, X-ray coronary angiography
is still preferred to give a more accurate overview of cor-
onary anatomy. In adolescents and adults, if MRI is not
available, a combination of echocardiography and single-
photon emission computed tomography (SPECT) can be an
alternative to demonstrate anatomy, function, and perfu-
sion of the coronary arteries [17].
Therapy options for significant early- and late-coronary
artery stenosis in patients with KD vary from surgical
bypass insertion to different catheter interventional proce-
dures. In adults with coronary artery disease catheter
interventions are well established and undoubtedly of high
clinical value. However, in patients with KD, only limited
experiences and results with catheter interventions have
been reported [1, 2, 11, 20, 22, 24]. The success rate of
PTCA in patients with KD and coronary artery stenosis
seems to be limited due to a marked initimal thickening
with a high recoil capacity within the first years after acute
KD, and due to multiple calcifications with severely
reduced compliance of the arterial wall after long-term KD
[2, 11, 24]. High-pressure balloons with a maximum bal-
loon pressure [10 atm, which have been used in this sit-
uation, may lead to late neoaneurysm formation [2, 11, 24].
Moreover, the incidence of restenosis after PTCA has been
reported to be increased with a rate of 24% [2]. Never-
theless, PTCA has shown to be effective in selected cases
[20], especially in patients without severe calcification or
in patients with a relatively short interval between the onset
of the disease and the intervention.
In both of our patients, who received an interventional
treatment of their coronary stenosis, PTCA was not suc-
cessful and stent implantation was necessary. Stent place-
ment has been useful in older children with mild
calcifications and in children with giant aneurysms [11]. It
can be preferable to PTCA, because it may prevent new
aneurysm formation and restenosis [2, 4, 11, 24]. In
patients with severe calcified coronary stenosis percuta-
neous transluminal coronary rotational ablation (PTCRA)
may be the only effective interventional treatment option
[2, 11, 16, 24, 29]. High success rates[80% even in severe
calcifications justify its use and make it the option of
choice in this patient group [2, 16, 24, 29]. It is also rec-
ommended in cases where PTCA and/or stent implantation
was not successful.
At present, coronary artery bypass grafting (CABG) is
the preferred surgical treatment procedure for revasculari-
zation of ischemic myocardium due to stenotic lesions after
KD, using either a saphenous vein—with less good
results—or the internal thoracic artery. Compared with
catheter interventions, bypass surgery is preferred in
patients, who have vessels with multiple, ostial, or long-
segment lesions, and/or in patients with severe left ven-
tricular dysfunction [14, 21, 28, 32].
In our patients, all arterial grafts seem to be patent
during mid-term follow-up, whereas all venous grafts (in
one patient) showed complete occlusion within 1 year
despite an adequate anticoagulation regime.
The long-term results of arterial bypass grafting in KD
patients are encouraging. In a large published series with
100 patients, the patency rates were 94, 82, and 78% at 1,
5, and 10 years, respectively, whereas patency rates for
venous grafts were only 82, 63, and 36%, respectively [32].
Arterial internal mammary grafts may grow according to
the somatic growth of children, by this having the potential
to serve as ‘‘live’’ conduit in pediatric patients [14, 32]. In
young children, vessel diameters are small, which may
result in postoperative stenosis at the anastomotic site.
PTCA has been used successfully in pediatric patients after
KD for treating anastomotic stenosis. In a recently pub-
lished series, the long-term results of internal thoracic
artery bypasses in children \12 years have improved sig-
nificantly through PTCA for anastomotic stenosis and the
application of appropriate indications. The patency rates in
this patient group were [90% at 20 years [28].
Conclusions
Approximately 16% of the patients with initial coronary
aneurysms developed stenotic lesions with myocardial
ischemia requiring therapy during follow-up. The most
significant risk factor for the development of stenotic
lesions is an aneurysm-size [5.0 mm. ECG changes may
precede symptomatic ischemia for months. In case of new
and even unspecific ECG changes, advanced coronary
imaging modalities (angiography, MRI) have to be
considered.
Therapy options vary from percutaneous catheter inter-
ventions (PTCA, stent implantation, PTCRA) to bypass
surgery and have to be selected individually for each
patient. In our very limited experience, internal mammarial
artery bypass surgery has shown excellent mid-term results
in patients with coronary lesions after KD.
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